Piperacillin sodium

Piperacillin sodium is a broad-spectrum beta-lactam antibiotic of the ureidopenicillin class. It is commonly used in the treatment of moderate to severe bacterial infections, including those caused by susceptible strains of Enterobacteriaceae, Pseudomonas aeruginosa, and other gram-negative and gram-positive bacteria. Piperacillin sodium is often used in combination with a beta-lactamase inhibitor, such as tazobactam, to broaden its spectrum of activity against beta-lactamase-producing bacteria, a combination known as piperacillin/tazobactam.

Mechanism of Action

Piperacillin sodium exerts its bactericidal effects by inhibiting the synthesis of bacterial cell walls. It binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This inhibition of PBPs leads to the disruption of cell wall synthesis, resulting in bacterial cell lysis and death. Piperacillin sodium is most effective against bacteria that are actively multiplying and forming cell walls.

Pharmacokinetics

After intravenous administration, piperacillin sodium is distributed widely throughout the body, including into the peritoneal fluid, bile, and lung tissue. It is metabolized to a minor extent in the liver and is primarily excreted unchanged by the kidneys. The half-life of piperacillin sodium may be prolonged in patients with impaired renal function, necessitating dosage adjustments.

Clinical Uses

Piperacillin sodium is indicated for the treatment of a variety of infections caused by susceptible bacteria, including:

• Pneumonia
• Urinary tract infections
• Intra-abdominal infections
• Skin and skin structure infections
• Septicemia

When combined with tazobactam, piperacillin sodium's spectrum of activity is extended to include beta-lactamase-producing strains of bacteria, making it a valuable option for treating infections known or suspected to involve resistant organisms.

Adverse Effects

The most common adverse effects associated with piperacillin sodium include:

• Diarrhea
• Nausea and vomiting
• Rash
• Hypersensitivity reactions, including anaphylaxis in patients with a history of penicillin allergy
• Electrolyte imbalances, particularly hypokalemia
• Prolongation of bleeding time

Drug Interactions

Piperacillin sodium can interact with several other medications, including:

• Probenecid, which can decrease renal excretion of piperacillin and increase its blood levels
• Anticoagulants, such as warfarin, due to the potential for increased bleeding risk
• Other nephrotoxic drugs, which may increase the risk of renal toxicity

Conclusion

Piperacillin sodium is a critical agent in the management of serious bacterial infections, especially those caused by resistant organisms. Its use, particularly in combination with tazobactam, represents an important option in the antimicrobial arsenal against challenging infections. However, careful consideration of potential adverse effects and drug interactions is essential to optimize therapeutic outcomes.

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian